NCT00003469View on ClinicalTrials.gov

Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System

PHASE2TerminatedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

February 29, 1996

Primary Completion Date

May 31, 2003

Study Completion Date

May 31, 2003

Conditions
Rhabdoid Neoplasm of CNS
Interventions
DRUG

Antineoplaston therapy (Atengenal + Astugenal)

Children with a Rhabdoid tumor will receive Antineoplaston therapy (Atengenal + Astugenal).

Trial Locations (1)

77055-6330

Burzynski Clinic, Houston

Sponsors
All Listed Sponsors
lead

Burzynski Research Institute

OTHER